Milan, February 7, 2020 – daVinci Digital Therapeutics Srl, a Digital Biotech Company developing prescription digital therapeutics to treat mental health and metabolic diseases, today announced that Giuseppe Recchia, Co-Founder and CEO, will participate in EUCROF 2020, the 5th European Conference On Clinical Research.
On the 10th and 11th February 2020, EUCROF2020, the 5th European Conference on Clinical Research, will be held in Amsterdam.
The event will discuss the main challenges and future pharmaceutical and biotechnological scenario, with the ultimate goal of improving patient health.
The 2020 main theme is ”Science, Technology and legislations that come together to improve patient health”.
Digital Therapeutics are an emerging class of medicines that deliver evidence-based therapeutic interventions to patients.
Giuseppe Recchia, Co-Founder and CEO daVinci Digital Therapeutics, will deliver a lecture on “Research and Development of Digital Therapeutics #DTx, a new generation of evidencebased prescription interventions” in the “Today’s Future” Session on February 12, 2020